Paul G. Richardson

Boston University (US)

Research Areas

Discover Papers by Paul G. Richardson

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

170

Publications

2057

Citations

131469

i10-index

881

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
International Myeloma Working Group updated criter...	2014	4771
International Myeloma Working Group consensus crit...	2016	2911
BET Bromodomain Inhibition as a Therapeutic Strate...	2011	2820
A Phase 2 Study of Bortezomib in Relapsed, Refract...	2003	2633
International uniform response criteria for multip...	2006	2628
Bortezomib or High-Dose Dexamethasone for Relapsed...	2005	2489
Bortezomib plus Melphalan and Prednisone for Initi...	2008	1901
The proteasome inhibitor PS-341 inhibits growth, i...	2001	1529
Daratumumab, Lenalidomide, and Dexamethasone for M...	2016	1422
Elotuzumab Therapy for Relapsed or Refractory Mult...	2015	1312

Publications

1.
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Year: 2014Citations: 4771DOI: 10.1016/s1470-2045(14)70442-5
2.
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Year: 2016Citations: 2911DOI: 10.1016/s1470-2045(16)30206-6
3.
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Year: 2011Citations: 2820DOI: 10.1016/j.cell.2011.08.017
4.
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Year: 2003Citations: 2633DOI: 10.1056/nejmoa030288
5.
International uniform response criteria for multiple myeloma
Year: 2006Citations: 2628DOI: 10.1038/sj.leu.2404284
6.
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Year: 2005Citations: 2489DOI: 10.1056/nejmoa043445
7.
Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
Year: 2008Citations: 1901DOI: 10.1056/nejmoa0801479
8.
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.
Year: 2001Citations: 1529
9.
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
Year: 2016Citations: 1422DOI: 10.1056/nejmoa1607751
10.
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
Year: 2015Citations: 1312DOI: 10.1056/nejmoa1505654

About Paul G. Richardson

Paul G. Richardson is a researcher with 2057 publications and 131469 citations. They are affiliated with Boston University. Their research focuses on . With an h-index of 170, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Paul G. Richardson and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year